Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8 Purity>98.0% (GC) Lenvatinib Mesylate Intermediate Factory
Ruifu Chemical Supply Lenvatinib Mesylate Intermediates Ndi Kuyera Kwambiri
Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
Desquinolinyl Lenvatinib;1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene) -2,2-Dimethyl-1,3-Dioxane-4,6-Dione CAS 15568-85-1
4-Amino-3-Chlorophenol CAS 17609-80-2
4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Dzina la Chemical | Methyl 4-Amino-2-Methoxybenzoate |
Mawu ofanana ndi mawu | 4-Amino-2-Methoxybenzoic Acid Methyl Ester;Methyl 4-Amino-o-Anisate;4-Amino-o-Anisic Acid Methyl Ester |
Nambala ya CAS | 27492-84-8 |
Nambala ya CAT | Mtengo wa RF-PI1974 |
Stock Status | Mu Stock, Kupanga Kukula Mpaka Matani |
Molecular Formula | C9H11NO3 |
Kulemera kwa Maselo | 181.19 |
Kuchulukana | 1.179±0.060 g/cm3 |
Mtundu | Ruifu Chemical |
Kanthu | Zofotokozera |
Maonekedwe | Ufa Woyera mpaka Woyera kapena Makristalo |
Kuyera / Kusanthula Njira | >98.0% (GC) |
Kuyera / Kusanthula Njira | 97.5 ~ 102.5 (Nonaqueous Titration) |
Melting Point | 157.0 ~ 161.0 ℃ |
Kutaya pa Kuyanika | <1.00% |
Zonse Zonyansa | <2.0% |
Infrared Spectrum | Zimagwirizana ndi Kapangidwe |
Proton NMR Spectrum | Zimagwirizana ndi Kapangidwe |
Test Standard | Enterprise Standard |
Kugwiritsa ntchito | Pakati pa Lenvatinib Mesylate (CAS: 857890-39-2) |
Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi lamulo la kasitomala
Mkhalidwe Wosungira:Sungani muzitsulo zosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi
Methyl 4-Amino-2-Methoxybenzoate (CAS: 27492-84-8) angagwiritsidwe ntchito ngati wapakatikati wa Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib ndi mankhwala a khansa ya chithokomiro opangidwa ndi Eisai Corporation yaku Japan (Code: E7080), ya inhibitor ya oral multi-receptor tyrosine kinase (RTK) ndipo imatha kuletsa ntchito ya kinase ya vascular endothelial growth factor (VEGF) Receptors VEGFR1 ( FLT1), VEGFR2 (KDR), ndi VEGFR3 (FLT4).Lenvatinib ingalepheretsenso kukhudzidwa kwa ma RTK ena mu pathological angiogenesis, kukula kwa chotupa, ndi kukula kwa khansa kupatulapo ntchito zawo zachibadwa zama cell kuphatikizapo fibroblast growth factor (FGF) zolandilira FGFR1, 2, 3, ndi 4;Kukula kwa ma platelet-derived growth factor receptor (PDGFR [alpha]), KIT, ndi RET.[Zizindikiro]: Lenvatinib ndi oyenera kuchiza odwala a chithokomiro khansa ya m'deralo zisadzachitikenso kapena metastasis mtundu, progressivity mtundu ndi radioactive ayodini-refractory differentiated mtundu.Pa February 13, 2015, US FDA idavomereza Lenvatinib mankhwala ochizira khansa ya chithokomiro.Lenvatinib ndi multi-target enzyme inhibitor, yomwe imatha kuletsa VEGFR2 ndi VEGFR3 (vascular endothelial growth factor receptor).Dzina la malonda la Lenvatinib ndi Lenvima.Pa Meyi 20, 2015, European Medicines Agency (EMA) idavomereza Lenvatinib kuti azitha kuchiza khansa ya chithokomiro, yapapillary, follicular, mtundu wa Hurthle (DTC).M'mayeserowo, nthawi yapakati yopulumuka kwa odwala omwe adalandira chithandizo cha radioactive ayodini-refractory DTC omwe adalandira chithandizo ndi Lenvatinib anali miyezi 18 pomwe mtengo wa odwala omwe atenga placebo ndi miyezi itatu yokha.